Gadoterate Meglumine Injectable Solution bulk supplier for pharma manufacturers

Gadoterate Meglumine Injectable Solution 0.5 mol/L Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 0.5 mol/L

Reference Brands: Dotarem(US & EU)

Gadoterate meglumine is a gadolinium-based contrast agent that shortens relaxation times in MRI scans, enhancing tissue and blood vessel visibility. It provides clear, high-resolution images of the brain, spine, and joints. Benefits include improved diagnostic accuracy, rapid imaging, safety, and support for effective detection of abnormalities.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Gadoterate meglumine, marketed as Dotarem, is approved in the US by the FDA and in the EU via EMA for MRI diagnostics of brain, spinal cord, and joints. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports swift approval, safe administration, and global availability, assisting healthcare providers worldwide in delivering high-quality diagnostic imaging.

Gadoterate Meglumine Injectable Solution — third party manufacturing & bulk supply

Gadoterate Meglumine Injectable Solution 0.5 mol/L is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Gadoterate Meglumine Injectable Solution is supplied as Injectable Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Gadoterate Meglumine Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Gadoterate Meglumine Injectable Solution →

Back to Listing

Frequently Asked Questions

Gadoterate Meglumine Injectable Solution is listed as Injectable Solution in 0.5 mol/L. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Gadoterate Meglumine Injectable Solution is referenced against Dotarem(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.